HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intracoronary injection of CD34-cells in chronic ischemic heart failure: 7 years follow-up of the DanCell study.

AbstractOBJECTIVES:
Seven years ago, the DanCell study was carried out to test the hypothesis of improvement in left ventricular ejection fraction (LVEF) following repeated intracoronary injections of autologous bone marrow-derived stem cells (BMSCs) in patients suffering from chronic ischemic heart failure. In this post hoc analysis, the long-term effect of therapy is assessed.
METHODS:
32 patients [mean age 61 (SD ± 9), 81% males] with systolic dysfunction (LVEF 33 ± 9%) received two repeated intracoronary infusions (4 months apart) of autologous BMSCs (1,533 ± 765 × 10(6) BMSCs including 23 ± 11 × 10(6) CD34(+) cells and 14 ± 7 × 10(6) CD133(+) cells). Patients were followed for 7 years and deaths were recorded.
RESULTS:
During follow-up, 10 patients died (31%). In univariate regression analysis, the total number of BMSCs, CD34(+) cell count and CD133(+) cell count did not significantly correlate with survival (hazard ratio: 0.999, 95% CI: 0.998-1.000, p = 0.24; hazard ratio: 0.94, 95% CI: 0.88-1.01, p = 0.10, and hazard ratio: 0.96, 95% CI: 0.87-1.07, p = 0.47, respectively). After adjustment for baseline variables in multivariate regression analysis, the CD34(+) cell count was significantly associated with survival (hazard ratio: 0.90, 95% CI: 0.82-1.00, p = 0.04).
CONCLUSIONS:
Intracoronary injections of a high number of CD34(+) cells may have a beneficial effect on chronic ischemic heart failure in terms of long-term survival.
AuthorsMorten Hansen, Sebastian Nyby, Jacob Eifer Møller, Lars Videbæk, Moustapha Kassem, Torben Barington, Per Thayssen, Axel Cosmus Pyndt Diederichsen
JournalCardiology (Cardiology) Vol. 129 Issue 2 Pg. 69-74 ( 2014) ISSN: 1421-9751 [Electronic] Switzerland
PMID25116577 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, CD34
Topics
  • Adolescent
  • Adult
  • Aged
  • Antigens, CD34
  • Bone Marrow Transplantation (methods)
  • Chronic Disease
  • Female
  • Follow-Up Studies
  • Heart Failure (therapy)
  • Humans
  • Infusions, Intralesional
  • Injections, Intralesional
  • Male
  • Middle Aged
  • Myocardial Ischemia (therapy)
  • Stem Cell Transplantation (methods)
  • Transplantation, Autologous (methods)
  • Treatment Outcome
  • Ventricular Dysfunction, Left (therapy)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: